Gürkan Kaya

Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma

Ximena Bonilla, Laurent Parmentier, Bryan H. King et al. · Nature Genetics · 2016 · 482 citations

Progression Pathways, Genomic Analysis, Melanoma +7

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema

Sébastien Menzinger, Aysin Kaya, Jean‐Hilaire Saurat et al. · Dermatopathology · 2016 · 399 citations · Full text

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Julie-Anne Dayer, Sabine Yerly et al. · The Lancet Infectious Diseases · 2015 · 276 citations

Vaccination, Vaccine Safety, Vaccinology +9

Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.

Gürkan Kaya, Iván Rodríguez, José L. Jorcano et al. · Genes & Development · 1997 · 273 citations · Full text

Impairs Keratinocyte Proliferation, Antisense Cd44 Transgene, Corneal Dystrophy +14